Top
Mediastinal Low-Grade Fibromyxoid Sarcoma With FUS-CREB3L2 Gene Fusion
Mediastinal Low-Grade Fibromyxoid Sarcoma With FUS-CREB3L2 Gene Fusion
DOI: 10.7759/cureus.15606, Volume: 13, Issue: 6, Pages: 0-0
Article Type: case-report,
Article History
accepted:
published:
-
-
-
- Altmetric
https://www.researchpad.co/tools/openurl?pubtype=&doi=10.7759/cureus.15606&title=Mediastinal Low-Grade Fibromyxoid Sarcoma With FUS-CREB3L2 Gene Fusion&author=&keyword=[{keywordId=58, uniqueName=cancer-immunotherapy, name=Cancer immunotherapy, contentId=265695}, {keywordId=200449, uniqueName=targeted-therapeutics, name=targeted therapeutics, contentId=265695}, {keywordId=327635, uniqueName=low-grade-fibromyxoid-sarcoma, name=low-grade fibromyxoid sarcoma, contentId=265695}, {keywordId=327636, uniqueName=sclerosing-epithelioid-fibrosarcoma, name=sclerosing epithelioid fibrosarcoma, contentId=265695}, {keywordId=327637, uniqueName=mediastinal-sarcoma, last=true, name=mediastinal sarcoma, contentId=265695}],[{keywordId=58, uniqueName=cancer-immunotherapy, name=Cancer immunotherapy, contentId=265695}, {keywordId=200449, uniqueName=targeted-therapeutics, name=targeted therapeutics, contentId=265695}, {keywordId=327635, uniqueName=low-grade-fibromyxoid-sarcoma, name=low-grade fibromyxoid sarcoma, contentId=265695}, {keywordId=327636, uniqueName=sclerosing-epithelioid-fibrosarcoma, name=sclerosing epithelioid fibrosarcoma, contentId=265695}, {keywordId=327637, uniqueName=mediastinal-sarcoma, last=true, name=mediastinal sarcoma, contentId=265695}],[{keywordId=58, uniqueName=cancer-immunotherapy, name=Cancer immunotherapy, contentId=265695}, {keywordId=200449, uniqueName=targeted-therapeutics, name=targeted therapeutics, contentId=265695}, {keywordId=327635, uniqueName=low-grade-fibromyxoid-sarcoma, name=low-grade fibromyxoid sarcoma, contentId=265695}, {keywordId=327636, uniqueName=sclerosing-epithelioid-fibrosarcoma, name=sclerosing epithelioid fibrosarcoma, contentId=265695}, {keywordId=327637, uniqueName=mediastinal-sarcoma, last=true, name=mediastinal sarcoma, contentId=265695}],[{keywordId=58, uniqueName=cancer-immunotherapy, name=Cancer immunotherapy, contentId=265695}, {keywordId=200449, uniqueName=targeted-therapeutics, name=targeted therapeutics, contentId=265695}, {keywordId=327635, uniqueName=low-grade-fibromyxoid-sarcoma, name=low-grade fibromyxoid sarcoma, contentId=265695}, {keywordId=327636, uniqueName=sclerosing-epithelioid-fibrosarcoma, name=sclerosing epithelioid fibrosarcoma, contentId=265695}, {keywordId=327637, uniqueName=mediastinal-sarcoma, last=true, name=mediastinal sarcoma, contentId=265695}],[{keywordId=58, uniqueName=cancer-immunotherapy, name=Cancer immunotherapy, contentId=265695}, {keywordId=200449, uniqueName=targeted-therapeutics, name=targeted therapeutics, contentId=265695}, {keywordId=327635, uniqueName=low-grade-fibromyxoid-sarcoma, name=low-grade fibromyxoid sarcoma, contentId=265695}, {keywordId=327636, uniqueName=sclerosing-epithelioid-fibrosarcoma, name=sclerosing epithelioid fibrosarcoma, contentId=265695}, {keywordId=327637, uniqueName=mediastinal-sarcoma, last=true, name=mediastinal sarcoma, contentId=265695}],&subject=
© 2024 Newgen KnowledgeWorks |
Privacy & Cookie Policy | Powered by: Nova